Hartford Investment Management Co. Reduces Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hartford Investment Management Co. cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,322 shares of the medical equipment provider’s stock after selling 406 shares during the period. Hartford Investment Management Co.’s holdings in Intuitive Surgical were worth $10,966,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in ISRG. NBC Securities Inc. lifted its stake in shares of Intuitive Surgical by 34.4% during the first quarter. NBC Securities Inc. now owns 121 shares of the medical equipment provider’s stock valued at $48,000 after buying an additional 31 shares during the period. Dynamic Advisor Solutions LLC lifted its position in Intuitive Surgical by 14.4% during the first quarter. Dynamic Advisor Solutions LLC now owns 9,993 shares of the medical equipment provider’s stock valued at $3,988,000 after buying an additional 1,255 shares in the last quarter. Hoxton Planning & Management LLC purchased a new stake in Intuitive Surgical during the first quarter worth approximately $203,000. Elevated Capital Advisors LLC increased its position in shares of Intuitive Surgical by 2.8% in the first quarter. Elevated Capital Advisors LLC now owns 1,556 shares of the medical equipment provider’s stock worth $621,000 after acquiring an additional 42 shares in the last quarter. Finally, Brookstone Capital Management raised its stake in shares of Intuitive Surgical by 17.2% in the 1st quarter. Brookstone Capital Management now owns 10,241 shares of the medical equipment provider’s stock valued at $4,087,000 after acquiring an additional 1,505 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have commented on ISRG. Piper Sandler reissued an “overweight” rating and issued a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Citigroup upped their price target on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded down $4.50 during mid-day trading on Wednesday, hitting $513.00. The company had a trading volume of 82,817 shares, compared to its average volume of 1,470,277. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $523.34. The stock has a market cap of $181.96 billion, a price-to-earnings ratio of 93.41, a PEG ratio of 5.40 and a beta of 1.39. The firm’s 50 day simple moving average is $485.88 and its two-hundred day simple moving average is $440.46.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the sale, the executive vice president now owns 7,066 shares of the company’s stock, valued at $3,638,990. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Amy L. Ladd sold 450 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the sale, the director now directly owns 821 shares in the company, valued at $402,519.88. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now owns 7,066 shares of the company’s stock, valued at $3,638,990. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 51,455 shares of company stock worth $24,911,155. 0.90% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.